Thursday, July 24, 2025

Creating liberating content

Sundar Pichai, CEO of Alphabet Inc., during Stanford’s 2024 Business,

The SK Hynix Inc. logo is displayed on a glass

Here’s what medical experts say:Yes, early-onset Alzheimer’s is real, but

Bill McDermott, Chairman, President & CEO ServiceNow, speaking on CNBC’s

Related News

Sundar Pichai, CEO of Alphabet Inc., during Stanford’s 2024 Business, Government, and Society forum in Stanford, California, April 3, 2024. Justin Sullivan | Getty Images Google is going to spend

The SK Hynix Inc. logo is displayed on a glass door at the company’s office in Seoul, South Korea, on Monday, Jan. 27, 2014. SK Hynix aims to select a

Here’s what medical experts say:Yes, early-onset Alzheimer’s is real, but extremely rare in those under 30. According to the Alzheimer’s Association, less than 5% of all Alzheimer’s cases are early-onset

Bill McDermott, Chairman, President & CEO ServiceNow, speaking on CNBC’s Squawk Box at the World Economic Forum Annual Meeting in Davos, Switzerland on Jan. 17th, 2024. Adam Galici | CNBC

IBM CEO Arvind Krishna appears at the World Economic Forum in Davos, Switzerland, on Jan. 16, 2024. Stefan Wermuth | Bloomberg | Getty Images IBM shares fell as much as

India’s ambitions in electronics, electric vehicles (EVs), and clean energy may face critical challenges due to its limited domestic production of rare earth elements (REEs), despite holding sizable reserves. China

Trending News

India’s ambitions in electronics, electric vehicles (EVs), and clean energy may face critical challenges due to its limited domestic production of rare earth elements (REEs), despite holding sizable reserves. China

India’s efforts to strengthen its global trade ties, including the upcoming free trade agreement (FTA) with the UK, present a timely strategic opportunity amid rising global uncertainties, the Reserve Bank

Access Denied You don’t have permission to access ” on this server. Reference #18.4cfdd417.1753295731.13429908 Source link

BENGALURU: Good Glamm Group’s managing director and CEO Darpan Sanghvi has confirmed that the company will no longer operate as a single consumer goods entity, with lenders now enforcing their

BENGALURU: Syngene International, a subsidairy of Biocon, reported a 59 per cent year-on-year increase in profit after tax to Rs 87 crore in the first quarter ended June 2025, aided

BENGALURU: The Enforcement Directorate has filed a formal complaint against Myntra Designs Pvt Ltd and its related entities for allegedly violating India’s foreign direct investment (FDI) norms under the guise

KKR, JB Chemicals promoter, to sell 10% for Rs 2.6k crore

Word Count: 452 | Estimated Reading Time: 3 minutes


KKR, JB Chemicals promoter, to sell 10% for Rs 2.6k crore

MUMBAI: Tau Investment Holdings, an arm of global private equity major KKR, the promoter of JB Chemicals, is selling about 1.6 crore shares (10.2%) of the company for about Rs 2,575 crore ($300 million) through block deals on Thursday.
The shares are being sold at a floor price of Rs 1,625, about 5% discount to JB Chem’s Wednesday NSE closing price of Rs 1,709, the term sheet for the deal showed. According to shareholding disclosures on the BSE, as of Dec 31, 2024, KKR was holding 53.7% in the city-based pharmaceuticals company. The PE major had acquired the majority control in the drug maker in mid-2020 at Rs 745 per share.
The base offer in the deal is for nearly 1.1 crore shares (about 6.8%) of JB Chem that could bring in about Rs 1,717 crore for KKR.





Source link

Most Popular Articles

Sign In

Welcome ! Log into Your Account